MFDS
- Status: likely_approved
🇰🇷 Neulasta in South Korea
Neulasta (Pegfilgrastim-Apgf) regulatory status in South Korea.
Marketing authorisation
Neulasta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Neulasta approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Neulasta in South Korea?
Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.